Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 1/20 | 0.49 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | STK10 | O94804 | 1/20 | 0.45 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | PIM1 | P11309 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.43 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15853175 | 0.94 | ADRA2C (0.54) | ADRA2CPDK2MCL1ADORA2ASTK10 | |
| SCHEMBL13170801 | 0.90 | ADRA2C (0.44) | ADRA2CPDK2MCL1ADORA2ASTK10 | |
| SCHEMBL10051153 | 0.89 | MCL1 (0.47) | MCL1STK10SLKCA1CA2 | |
| SCHEMBL26750958 | 0.87 | CYP1A2 (0.49) | MCL1CA1CA2PIM1CYP1A2 | |
| SCHEMBL10051189 | 0.87 | CYP1A2 (0.49) | MCL1CA1CA2PIM1CYP1A2 | |
| SCHEMBL13170796 | 0.87 | CA1 (0.48) | ADRA2CPDK2MCL1ADORA2ASTK10 | |
| SCHEMBL28520824 | 0.85 | ADORA2A (0.47) | ADRA2CPDK2MCL1ADORA2ASTK10 | |
| SCHEMBL13170973 | 0.84 | PGR (0.47) | ADRA2CPDK2MCL1ADORA2ACA1 | |
| SCHEMBL10296082 | 0.83 | CYP1A2 (0.51) | MCL1CA1CA2PIM1CYP1A2 | |
| SCHEMBL13170804 | 0.83 | PIM1 (0.45) | ADRA2CPDK2MCL1ADORA2ASTK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015089028-A1 | PHOTOACTIVE COMPOSITIONS FOR ELECTRONIC APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-06-18 | — | — | WO | disclosed |
| WO-2015089028-A1 | PHOTOACTIVE COMPOSITIONS FOR ELECTRONIC APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-06-18 | — | — | WO | disclosed |
| US-20120187383-A1 | ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-26 | — | — | US | disclosed |
| US-20120187383-A1 | ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-26 | — | — | US | disclosed |
| WO-2012021315-A2 | ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120187383-A1 | ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | CCNL2, ESR1, ESR2 | ADRA2C 306/4885PDK2 3073/4885MCL1 3879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.